Stock Yards Bank & Trust Co. Has $7.06 Million Stock Position in Danaher Corporation $DHR

Stock Yards Bank & Trust Co. lowered its stake in Danaher Corporation (NYSE:DHR) by 15.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 35,623 shares of the conglomerate’s stock after selling 6,678 shares during the quarter. Stock Yards Bank & Trust Co.’s holdings in Danaher were worth $7,063,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. WFA of San Diego LLC acquired a new stake in shares of Danaher during the second quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new stake in Danaher during the 2nd quarter valued at $27,000. TruNorth Capital Management LLC purchased a new stake in shares of Danaher in the third quarter valued at $28,000. Tripletail Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter valued at $31,000. Finally, Red Tortoise LLC boosted its position in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the transaction, the senior vice president owned 14,553 shares of the company’s stock, valued at approximately $3,190,454.19. This represents a 59.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the transaction, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,248 shares of company stock valued at $6,609,663 over the last three months. 11.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on DHR shares. Rothschild & Co Redburn reissued a “neutral” rating and set a $220.00 price target (down from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Morgan Stanley began coverage on Danaher in a report on Monday, December 1st. They issued an “overweight” rating and a $270.00 target price on the stock. Evercore ISI reissued an “outperform” rating and issued a $250.00 price target on shares of Danaher in a research report on Monday, January 5th. Wells Fargo & Company boosted their price objective on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Finally, Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Twenty-one research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $251.87.

Danaher Trading Down 0.8%

Shares of NYSE DHR opened at $234.11 on Wednesday. The business has a 50 day simple moving average of $229.17 and a 200 day simple moving average of $212.44. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23. The stock has a market cap of $165.36 billion, a price-to-earnings ratio of 48.27, a PEG ratio of 4.20 and a beta of 0.89. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher (NYSE:DHR) last posted its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the company earned $1.71 earnings per share. The company’s revenue was up 4.4% compared to the same quarter last year. On average, research analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.5%. Danaher’s dividend payout ratio is currently 26.39%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.